39 related articles for article (PubMed ID: 25649006)
1. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidase 10 predicts prognosis and mediates tumor immunomodulation in colorectal cancer.
Luo YC; Lv YL; He RX; Shi XX; Jiang T
Biochem Biophys Res Commun; 2023 Dec; 689():149217. PubMed ID: 37972446
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein 6 protease advances colon tumorigenesis
Chen H; Sells E; Pandey R; Abril ER; Hsu CH; Krouse RS; Nagle RB; Pampalakis G; Sotiropoulou G; Ignatenko NA
Oncotarget; 2019 Oct; 10(58):6062-6078. PubMed ID: 31692974
[TBL] [Abstract][Full Text] [Related]
4. Ectopic expression of KLK6 in MDA-MB-435 melanoma cells reduces tumorigenicity in vivo.
Pampalakis G; Zingkou E; Zoumpourlis V; Sotiropoulou G
Pathol Res Pract; 2021 Jan; 217():153276. PubMed ID: 33249398
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Structure-Activity Relationships of N-(4-Benzamidino)-Oxazolidinones: Potent and Selective Inhibitors of Kallikrein-Related Peptidase 6.
De Vita E; Smits N; van den Hurk H; Beck EM; Hewitt J; Baillie G; Russell E; Pannifer A; Hamon V; Morrison A; McElroy SP; Jones P; Ignatenko NA; Gunkel N; Miller AK
ChemMedChem; 2020 Jan; 15(1):79-95. PubMed ID: 31675166
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme.
Vidone M; Clima R; Santorsola M; Calabrese C; Girolimetti G; Kurelac I; Amato LB; Iommarini L; Trevisan E; Leone M; Soffietti R; Morra I; Faccani G; Attimonelli M; Porcelli AM; Gasparre G
Int J Biochem Cell Biol; 2015 Jun; 63():46-54. PubMed ID: 25668474
[TBL] [Abstract][Full Text] [Related]
7. Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
Ni Y; Seballos S; Ganapathi S; Gurin D; Fletcher B; Ngeow J; Nagy R; Kloos RT; Ringel MD; LaFramboise T; Eng C
Endocr Relat Cancer; 2015 Apr; 22(2):121-30. PubMed ID: 25694510
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.
Raphael BJ; Vandin F
J Comput Biol; 2015 Jun; 22(6):510-27. PubMed ID: 25785493
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.
Tsai YS; Dominguez D; Gomez SM; Wang Z
Oncotarget; 2015 Mar; 6(9):6825-39. PubMed ID: 25749525
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers.
Gökmen-Polar Y; Vladislav IT; Neelamraju Y; Janga SC; Badve S
Sci Rep; 2015 Mar; 5():8765. PubMed ID: 25739705
[TBL] [Abstract][Full Text] [Related]
11. Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.
Dienstmann R; Jang IS; Bot B; Friend S; Guinney J
Cancer Discov; 2015 Feb; 5(2):118-23. PubMed ID: 25656898
[TBL] [Abstract][Full Text] [Related]
12. circSSPO boosts growth of esophageal squamous cell carcinoma through upregulation of micrRNA-6820-5p-mediated KLK8 and PKD1 expression.
Luo Q; Li J; Miao H; Su S; Chen Y; Xu C; Zhao C; Huang J; Ling K; Lin C; Yan H; Zhang S
Cell Biol Toxicol; 2023 Dec; 39(6):3219-3234. PubMed ID: 37812360
[TBL] [Abstract][Full Text] [Related]
13. Zinc Gluconate Induces Potentially Cancer Chemopreventive Activity in Barrett's Esophagus: A Phase 1 Pilot Study.
Valenzano MC; Rybakovsky E; Chen V; Leroy K; Lander J; Richardson E; Yalamanchili S; McShane S; Mathew A; Mayilvaganan B; Connor L; Urbas R; Huntington W; Corcoran A; Trembeth S; McDonnell E; Wong P; Newman G; Mercogliano G; Zitin M; Etemad B; Thornton J; Daum G; Raines J; Kossenkov A; Fong LY; Mullin JM
Dig Dis Sci; 2021 Apr; 66(4):1195-1211. PubMed ID: 32415564
[TBL] [Abstract][Full Text] [Related]
14. Urinary kallikrein 10 predicts the incurability of gastric cancer.
Shimura T; Ebi M; Yamada T; Yamada T; Katano T; Nojiri Y; Iwasaki H; Nomura S; Hayashi N; Mori Y; Kataoka H; Moses MA; Joh T
Oncotarget; 2017 Apr; 8(17):29247-29257. PubMed ID: 28418926
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Grin A; Samaan S; Tripathi M; Rotondo F; Kovacs K; Bassily MN; Yousef GM
Hum Pathol; 2015 Apr; 46(4):541-8. PubMed ID: 25649006
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer.
Kolin DL; Sy K; Rotondo F; Bassily MN; Kovacs K; Brezden-Masley C; Streutker CJ; Yousef GM
Biol Chem; 2014 Sep; 395(9):1087-93. PubMed ID: 25153389
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: mechanistic and clinical aspects.
Kontos CK; Mavridis K; Talieri M; Scorilas A
Thromb Haemost; 2013 Sep; 110(3):450-7. PubMed ID: 23446315
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
